The startup said it will use the funds to expand the rollout of its AI platform across cancer clinics, health systems, specialty pharmacies and infusion networks in the US, with the aim of speeding up access to cancer treatment.
RISA’s platform connects directly with hospital electronic medical records, insurance and benefits systems, and other tools used by cancer centres. Its AI agents automate tasks such as benefits verification and prior authorisation, replacing largely manual processes that often slow down treatment decisions.
RISA Labs had earlier raised $3.5 million in a seed funding round led by Flipkart cofounder Binny Bansal in April 2025.
Founded by IIT Kanpur alumni Kshitij Jaggi and Kumar Shivang, who earlier built healthcare startup Urban Health, RISA offers a workflow orchestration platform called BOSS (Business Operating System as a Service).
“In our vision for oncology, there are two sides to every patient’s journey: getting them on the right therapy faster, and deepening our understanding of the disease for the next patient through data,” said Jaggi, CEO of RISA Labs.
For one of its clients, RISA said its system has freed up nearly 80% of administrative staff time, reduced insurance denials by up to 40% and improved first-pass approval rates to 97.8%. Patient authorisations, which earlier took days, are now being filed within 24 hours, the startup said in a statement.
RISA provides hospitals a ‘BOSS Console’, its command control panel for mission-critical institutions. “BOSS Console is a low-entropy thinking information machine,” said Shivang, CTO of RISA Labs. “Modern oncology has created thousands of potential care paths for every patient. It has become essential to have an intelligent operating system that can absorb this complexity, remove administrative burden, and act as a companion to the most informed clinical decisions.”
Cencora Ventures said the need for such solutions is growing as cancer treatments become more specialised. “As oncology therapies increase in number and complexity, tools that streamline operations and enable faster access to treatment become vital,” said Jason Dinger, senior vice president at Cencora.